India, Uzbekistan Launch Pharma, Nutraceutical Trade Hub

• India and Uzbekistan launch new trade corridor to strengthen pharmaceutical and nutraceutical industry collaboration.
• Initiative aims to boost healthcare manufacturing, research partnerships, and cross-border market access.
• Corridor to be officially launched during Pharma Eurasia 2026 event in Tashkent.

India and Uzbekistan established a new pharmaceutical and nutraceutical trade corridor according to their announcement which serves as a strategic initiative to enhance their cooperation in healthcare manufacturing and research activities and cross-border trade.

The corridor connects the pharmaceutical and nutraceutical industries in both countries to establish better collaboration between their companies which will work together on production and distribution and innovation projects.

The initiative will create new business opportunities through its market connection which will also expand regional access to healthcare products.

The formal activation of the corridor is scheduled to take place during Pharma Eurasia 2026, a major industry event planned in Tashkent, Uzbekistan, from May 20 to May 22, 2026.

The event will bring together pharmaceutical companies, nutraceutical manufacturers, investors, policymakers, and healthcare experts from multiple countries.

Through this platform stakeholder will be able to explore business partnerships, investment opportunities and joint ventures which aim to strengthen supply chains and expand market reach.

Also read: Singapore Climate Plan Boosts Solar Power, Resilience Push

The initiative demonstrates a wider movement which aims to combine India's pharmaceutical manufacturing expertise with Uzbekistan's developing healthcare and life sciences industry.

India stands as one of the biggest worldwide producers of low-cost medicines and dietary supplements while Uzbekistan has dedicated resources to update its healthcare system and build international partnerships.

The trade corridor will establish pathways for both technology transfer and regulatory collaboration while enabling the creation of new healthcare solutions which will serve the needs of both nations.

The partnership intends to drive innovation through its work in the expanding nutraceutical industry which develops health supplements and functional foods that promote better health.

The two countries plan to enhance their pharmaceutical and nutraceutical industries through improved cooperation because they want to strengthen their healthcare systems while developing their industries and establishing better trade links between Central Asia and South Asia.

The new corridor serves as an important milestone which will help develop a more powerful life sciences ecosystem while establishing better international healthcare partnerships.